Filing Flows

Filing Flows › Krystal Biotech (KRYS) › Who owns the stock

Who owns Krystal Biotech (KRYS) stock

389 funds reported Krystal Biotech (KRYS) shares in their latest 13F filings, worth $11.4B in all. The largest holder is FMR LLC ($1.6B). Last quarter 232 funds added to their stakes and 124 cut them.

Largest holders of KRYS (13F)Largest holders of KRYS (13F)FMR LLC$1.6BBlackRock$1.6BAvoro Capital Advisors LLC$1.1BVanguard Group$685MVanguard Portfolio Management LLC$585MState Street$502MVanguard Capital Management LLC$461MSoleus Capital Management, L.P.$349MCapital World Investors$289MGeode Capital Management, LLC$260M

Largest holders (13F)

FundSharesValueChangeQuarter
FMR LLC4,418,197$1.6Bincrease2026-06-30
BlackRock4,181,432$1.6Bincrease2026-06-30
Avoro Capital Advisors LLC2,888,888$1.1Bunchanged2026-06-30
Vanguard Group2,778,845$685Mdecrease2025-12-31
Vanguard Portfolio Management LLC1,574,905$585Mincrease2026-06-30
State Street1,351,158$502Mincrease2026-06-30
Vanguard Capital Management LLC1,240,567$461Mincrease2026-06-30
Soleus Capital Management, L.P.939,254$349Mdecrease2026-06-30
Capital World Investors777,843$289Mdecrease2026-06-30
Geode Capital Management, LLC698,993$260Mincrease2026-06-30
Price T Rowe Associates687,400$255Mincrease2026-06-30
Hood River Capital Management LLC663,375$247Mincrease2026-06-30
Redmile Group, LLC632,005$235Mdecrease2026-06-30
William Blair Investment Management, LLC570,153$212Mincrease2026-06-30
Frazier Life Sciences Management, L.P.481,307$179Munchanged2026-06-30

Krystal Biotech's latest quarter

Krystal Biotech, Q3 2026: revenue $127M (+30% year over year), operating margin 55.9%, net earnings $63.1M, operating cash flow $91.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most KRYS stock?

By the latest 13F filings: FMR LLC ($1.6B); BlackRock ($1.6B); Avoro Capital Advisors LLC ($1.1B); Vanguard Group ($685M); Vanguard Portfolio Management LLC ($585M).

What is the short interest in KRYS?

2,936,047 shares were sold short at the 2026-10-15 settlement, -15.52% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.